Buy Sun Pharma, price target Rs 430: Gaurav Ratnaparkhi
The analyst suggested a stoploss at Rs 360.

Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 94377.84 Crore) operating in Pharmaceuticals sector.
Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 94377.84 Crore) operating in Pharmaceuticals sector.
Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 9783.29 Crore to Sales Value (94.95 % of Total Sales) and Other Operating Revenue which contributed Rs 519.92 Crore to Sales Value (5.04 % of Total Sales)for the year ending 31-Mar-2019.
For the quarter ended 31-12-2019, the company has reported a Consolidated sales of Rs 8038.65 Crore, up 1.13 % from last quarter Sales of Rs 7949.19 Crore and up 4.99 % from last year same quarter Sales of Rs 7656.71 Crore Company has reported net profit after tax of Rs 1023.71 Crore in latest quarter.
Download ET Markets APP